Showing results (721-730 of 1,794) with videos related to
Sort By:
Pageof 180
Mabs|January 5, 2010
Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial originMelarkode S Ramakrishnan, Anand Eswaraiah, Tania Crombet, et al.Mabs|December 22, 2016
Optimizing assembly and production of native bispecific antibodies by codon de-optimizationGiovanni Magistrelli, Yves Poitevin, Florence Schlosser, et al.Mabs|October 28, 2016
Fc-mediated activity of EGFR x c-Met bispecific antibody JNJ-61186372 enhanced killing of lung cancer cellsKatharine D Grugan, Keri Dorn, Stephen W Jarantow, et al.Mabs|January 6, 2017
Generation of a highly diverse panel of antagonistic chicken monoclonal antibodies against the GIP receptorJennifer D Könitzer, Shreya Pramanick, Qi Pan, et al.Mabs|December 23, 2016
Physicochemical and biological characterization of SB2, a biosimilar of Remicade® (infliximab)Juyong Hong, Yuhwa Lee, Changsoo Lee, et al.Mabs|February 5, 2014
In vitro affinity maturation of a natural human antibody overcomes a barrier to in vivo affinity maturationBing Li, Ashley E Fouts, Katharina Stengel, et al.Mabs|February 5, 2014
Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibodyCéline Monnet, Sylvie Jorieux, Nathalie Souyris, et al.Mabs|February 5, 2014
Comparative reactivity of human IgE to cynomolgus monkey and human effector cells and effects on IgE effector cell potencyLouise Saul, Debra H Josephs, Keith Cutler, et al.Mabs|February 5, 2014
Multiplexed screening of natural humoral immunity identifies antibodies at fine specificity for complex and dynamic viral targetsKrista M McCutcheon, Julia Gray, Natalie Y Chen, et al.Mabs|February 5, 2014
In vitro assessment of the effects of vedolizumab binding on peripheral blood lymphocytesTimothy Wyant, Lili Yang, Eric FedykPageof 180